ELISA-IgM-SARS-CoV‑2 test kit
The kit is intended for the qualitative determination of the content of class G immunoglobulins to SARS-CoV‑2 in human serum or plasma by enzyme immunoassay. The kit is intended for in vitro use only.
SARS-CoV‑2 is an enveloped single stranded (+) RNA virus belonging to the genus Betacoronavirus. First identified at the end of 2019. After entering the human body, it can cause a dangerous infectious disease – COVID-19, which can occur both in the form of an acute respiratory viral infection of the mild course, and in a severe form, the specific complications of which may include viral pneumonia, which entails acute respiratory distress syndrome or respiratory failure with risk of death.
Immunoglobulins G (IgG) are a class of antibodies that make up about 75% of human plasma antibodies and are the most commonly found antibodies in the bloodstream. IgGs take part in controlling infection throughout the body by binding to a wide variety of pathogens: viruses, bacteria, fungi. Binding of immunoglobulins G to pathogens causes them to immobilize and bind to each other (agglutination). IgG is involved mainly in the secondary immune response, is secreted as monomers that easily penetrate into tissues. Class G immunoglobulins are the only type of antibodies capable of crossing the placenta using special receptors, providing protection for the fetus in utero.
Determination of the content of IgG to SARS-CoV‑2 in blood plasma can help determine the formation of an immune response in patients with COVID-19 disease, as well as to assess the level of antibodies in the blood plasma of donors who have recovered.
|Immunoadsorbent||1 pce||2 – 8°С|
|Conjugate||12 mL||2 – 8°С|
|Positive Control||0,5 mL||2 – 8°С|
|Negative Control||1 mL||2 – 8°С|
|Sample Diluent||100 mL||2 – 8°С|
|Wash Concentrate(20x)*||20 mL||2 – 8°С|
|TMB Substrate *||12 mL||2 – 8°С|
|Stop Solution *||12 mL||2 – 8°С|